The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Contrast enhanced CT (CE-CT) changes and nephrometry down-scoring of unresectable primary renal cell carcinoma (RCC) tumors in patients (Pts) treated with neoadjuvant sunitinib.
Mohamed Salem
No relevant relationships to disclose
Shetal N. Shah
No relevant relationships to disclose
Laura S. Wood
No relevant relationships to disclose
Paul Elson
No relevant relationships to disclose
Avinash Medsinge
No relevant relationships to disclose
Steven Campbell
No relevant relationships to disclose
Brian I. Rini
No relevant relationships to disclose